ProtoKinetix, Incorporated
General ticker "PKTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.3M (TTM average)
ProtoKinetix, Incorporated does not follow the US Stock Market performance with the rate: -35.5%.
Estimated limits based on current volatility of 13.2%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 1 as of 2006
- Top business risk factors: Operational and conduct risks, Capital raising, Labor/talent shortage/retention, Regulatory and compliance, Market competition
- Current price 52.3% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.01$, 0.03$]
- 2024-12-30 to 2025-12-30 estimated range: [0.01$, 0.03$]
Financial Metrics affecting the PKTX estimates:
- Positive: with PPE of -14.2 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.46 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -1.02
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 90.69 > 63.39
Short-term PKTX quotes
Long-term PKTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.33MM | $1.91MM | $0.42MM |
| Operating Income | $-2.33MM | $-1.91MM | $-0.42MM |
| R&D Expense | $0.44MM | $0.45MM | $0.11MM |
| Income(Loss) | $-2.33MM | $-1.91MM | $-0.42MM |
| Profit(Loss)* | $-2.33MM | $-1.91MM | $-0.41MM |
| Stockholders Equity | $0.35MM | $0.42MM | $0.44MM |
| Assets | $0.45MM | $0.46MM | $0.48MM |
| Operating Cash Flow | $-0.89MM | $-0.80MM | $-0.38MM |
| Capital expenditure | $0.09MM | $0.13MM | $0.06MM |
| Investing Cash Flow | $-0.09MM | $-0.13MM | $-0.06MM |
| Financing Cash Flow | $0.84MM | $0.90MM | $0.43MM |
| Earnings Per Share** | $-0.01 | $-0.01 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.